“It was a good interactive conference, where many of my queries were very well answered and resolved”
Shilpa Kotian, Manager Regulatory Affairs, Umedica Laboratories

“The conference was useful for us to understand the regulatory and business challenges in the global market for generics”
Pritam P Wade, Senior Manager Regulatoy Affairs, Themis Medicare

“This conference was the first of its kind, brought major Indian and multi-national pharmaceutical and academic companies onto a single platform. It helped to understand the current trends and opportunities for future generic drug development. Great work!”
Shankar M Kurbet, Senior Pharmaceutical Scientist, Novartis Healthcare

“It was very useful in getting to know the status of the generic market in India and globally, for today and in the future”
Adnan Sabir, Vice President, Formulation and Scale-Up Team,
Dr Reddy's Laboratories

“This was a good initiative, provided a platform for pharma companies and regulators to discuss and strategise development plans”
Kanwal Tikoo,Director, Aptar Pharma India

“The conference attracted good speakers and interactive audience with equal opportunity for networking as well”
Alagh Subramaniam, Country Manager, West Pharmaceutical Packaging

“Perfect blend of the topics based in biosimilars. All the speakers were well educated and experienced on the respective topics”
Anita Ghagare, Senior Manager, Unichem Laboratories

“The conference was useful in providing knowledge on regulatory guidelines and process development”
Mannan Khambati, Senior Manager, Bharat Serums and Vaccines

“I could learn about biosimilar potential markets and regulatory developments”
Arumugam Muruganandam, Chief Scientific Manager, Head of Preclinical and Bioanalytical, Biocon

“It increased my knowledge about partnerships and regulatory developments in EU”
Laxmi Rao, General Manager, Biotechnology Research Labs, USV